Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
A Within-Sample Comparison of Two Innovative Neuropsychological Tests for Assessing ADHD.

Brain sciences

Baader A, Kiani B, Brunkhorst-Kanaan N, Kittel-Schneider S, Reif A, Grimm O.
PMID: 33396421
Brain Sci. 2020 Dec 31;11(1). doi: 10.3390/brainsci11010036.

New innovative neuropsychological tests in attention deficit hyperactivity disorder ADHD have been proposed as objective measures for diagnosis and therapy. The current study aims to investigate two different commercial continuous performance tests (CPT) in a head-to-head comparison regarding their...

Risk Stratification for Bipolar Disorder Using Polygenic Risk Scores Among Young High-Risk Adults.

Frontiers in psychiatry

Biere S, Kranz TM, Matura S, Petrova K, Streit F, Chiocchetti AG, Grimm O, Brum M, Brunkhorst-Kanaan N, Oertel V, Malyshau A, Pfennig A, Bauer M, Schulze TG, Kittel-Schneider S, Reif A.
PMID: 33192665
Front Psychiatry. 2020 Oct 26;11:552532. doi: 10.3389/fpsyt.2020.552532. eCollection 2020.

No abstract available.

The Quantified Behavioral Test-A Confirmatory Test in the Diagnostic Process of Adult ADHD?.

Frontiers in psychiatry

Brunkhorst-Kanaan N, Verdenhalven M, Kittel-Schneider S, Vainieri I, Reif A, Grimm O.
PMID: 32265761
Front Psychiatry. 2020 Mar 20;11:216. doi: 10.3389/fpsyt.2020.00216. eCollection 2020.

The differential diagnosis of attention deficit hyperactivity disorder (ADHD) in adulthood is complicated by comorbid disorders, but also by the overlapping of main symptoms such as inattentiveness, impulsivity, and hyperactivity with other disorders. Neuropsychological tests like continuous performance tests...

Prevalence of ADHD in Accident Victims: Results of the PRADA Study.

Journal of clinical medicine

Kittel-Schneider S, Wolff S, Queiser K, Wessendorf L, Meier AM, Verdenhalven M, Brunkhorst-Kanaan N, Grimm O, McNeill R, Grabow S, Reimertz C, Nau C, Klos M, Reif A.
PMID: 31597400
J Clin Med. 2019 Oct 08;8(10). doi: 10.3390/jcm8101643.

BACKGROUND: Recent research has shown an increased risk of accidents and injuries in ADHD patients, which could potentially be reduced by stimulant treatment. Therefore, the first aim of our study was to evaluate the prevalence of adult ADHD in...

Sphingolipid and Endocannabinoid Profiles in Adult Attention Deficit Hyperactivity Disorder.

Biomedicines

Brunkhorst-Kanaan N, Trautmann S, Schreiber Y, Thomas D, Kittel-Schneider S, Gurke R, Geisslinger G, Reif A, Tegeder I.
PMID: 34572359
Biomedicines. 2021 Sep 06;9(9). doi: 10.3390/biomedicines9091173.

Genes encoding endocannabinoid and sphingolipid metabolism pathways were suggested to contribute to the genetic risk towards attention deficit hyperactivity disorder (ADHD). The present pilot study assessed plasma concentrations of candidate endocannabinoids, sphingolipids and ceramides in individuals with adult ADHD...

Showing 1 to 5 of 5 entries